EBOV NP

EBOV NP Full Name

Ebola Virus Nucleocapsid Protein

EBOV NP Introduction

The Ebola virus nucleoprotein (NP) plays a critical role in the viral life cycle and is essential for the assembly of the viral nucleocapsid, which protects the viral RNA genome. The three-dimensional structure of NP has been characterized, revealing binding sites crucial for nucleocapsid formation and RNA encapsidation. Specific amino acid residues, such as Pro159, Lys160, and Val162, highlight the structural features necessary for NP functionality. Oligomerization of NP is critical for interactions with other viral proteins, facilitating RNA synthesis and transcription processes required for viral replication.

Figure 1. EBOV Nuclepootein (NP) Structure & Function.

NP functions through interactions with other viral proteins, particularly VP35, which acts as a chaperone stabilizing the NP-RNA complex. The absence of VP35 impairs genome transcription and replication, highlighting its essential role in polymerase activity. NP also engages with host cellular proteins such as RUVBL1 and RUVBL2, implicating it in transcriptional regulation and chromatin remodeling, which contributes to viral replication and pathogenesis. These multifaceted interactions emphasize NP's central role in the Ebola virus life cycle and its ability to coordinate viral and host factors.

Due to its abundance and conservation among EBOV strains, NP is a key target for immunological detection and vaccine development. Conserved epitopes enhance the utility of NP in diagnostic assays and cross-strain protection. Potential therapeutic strategies targeting NP include small molecules or ligands that disrupt its interaction with VP35 or interfere with nucleocapsid assembly. Understanding NP's structure, interactions, and antigenic properties provides crucial insights for the development of diagnostics, vaccines, and antiviral therapies, underscoring its importance in Ebola virus biology and disease management.

Alternate Names for EBOV NP

EBOV NP; Ebola Virus Nucleocapsid Protein; Ebola virus; EBOV; Nucleocapsid Protein; NP; Ebola virus NP

• 1. Nasution et al. Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola. BMC Bioinformatics. 2018;19(1):1-15.
  2. Schweneker et al. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles. Journal of Virology. 2017;91(5):e01981-16.
  3. Peng et al. In vitro assembly of Ebola virus nucleocapsid-like complex expressed in E. coli. Protein & Cell. 2016;7(3):163-174.
  4. Dong et al. Insight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 ? resolution. Protein & Cell. 2015;6(9):694-707.